This grant, offered by the Centers for Disease Control and Prevention (CDC), aims to continue public health surveillance to prevent or reduce complications associated with hemophilia and other congenital bleeding disorders. Since 1996, the CDC has funded a federal network of hemophilia treatment centers (HTCs) for collecting vital health data. This data is crucial for monitoring the health of individuals with bleeding disorders, tracking rates of complications like inhibitors, and ensuring blood and treatment product safety. Furthermore, the surveillance identifies high-risk populations for targeted prevention programs and highlights areas requiring further research. The purpose of this funding opportunity is to sustain these critical surveillance activities through the established HTC network, contributing to improved public health outcomes.
Opportunity ID: 275104
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD15-1507 |
| Funding Opportunity Title: | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.080 — Blood Disorder Program: Prevention, Surveillance, and Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Mar 13, 2015 |
| Last Updated Date: | May 14, 2015 |
| Original Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Jun 19, 2015 |
| Estimated Total Program Funding: | $4,300,000 |
| Award Ceiling: | $4,300,000 |
| Award Floor: | $100,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Applicants must provide documentation that HTCs have agreed to collaborate with the awardee and CDC to carry out the strategies and activities relevant to the HTCs that are proposed for this project. This documentation may be in the form of letters of support, letters of agreement, memoranda of understanding, memoranda of agreement, or contracts from or with collaborating HTCs (hereafter referred to collectively as “letters of support”). Documentation from the regional core center on behalf of the participating HTCs within its region may be provided in place of individual documentation from each HTC. If letters of support are not provided, the applicant will be considered non-responsive. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | Since the 1990s the congressional budget has included funds for the the Centers for Disease Control and Prevention (CDC) to reduce or prevent the complications of hemophilia and other congenital bleeding disorders. Since 1996 the CDC has funded the federal network of hemophilia treatment centers (HTCs) for the collection of data for the monitoring of health indicators of importance to persons with bleeding disorders. This data is used to measure rates of complications of bleeding disorders and monitor trends over time (including inhibitors and other issues of blood and treatment product safety); identify high risk populations for prevention programs; and identify issues that require research. The purpose of this FOA is to continue the surveillance for these conditions through the HTCs. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Meredith Oakley
mco6@cdc.gov Email:mco6@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. | May 14, 2015 | |
| Jun 18, 2016 | ||
| DD15-1507 supporting documents | May 14, 2015 | |
| DD15-1507 supporting documents | Mar 13, 2015 | |
| Mar 13, 2015 |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD15-1507 |
| Funding Opportunity Title: | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.080 — Blood Disorder Program: Prevention, Surveillance, and Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Mar 13, 2015 |
| Last Updated Date: | May 14, 2015 |
| Original Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Jun 19, 2015 |
| Estimated Total Program Funding: | $4,300,000 |
| Award Ceiling: | $4,300,000 |
| Award Floor: | $100,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Applicants must provide documentation that HTCs have agreed to collaborate with the awardee and CDC to carry out the strategies and activities relevant to the HTCs that are proposed for this project. This documentation may be in the form of letters of support, letters of agreement, memoranda of understanding, memoranda of agreement, or contracts from or with collaborating HTCs (hereafter referred to collectively as “letters of support”). Documentation from the regional core center on behalf of the participating HTCs within its region may be provided in place of individual documentation from each HTC. If letters of support are not provided, the applicant will be considered non-responsive. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | Since the 1990s the congressional budget has included funds for the the Centers for Disease Control and Prevention (CDC) to reduce or prevent the complications of hemophilia and other congenital bleeding disorders. Since 1996 the CDC has funded the federal network of hemophilia treatment centers (HTCs) for the collection of data for the monitoring of health indicators of importance to persons with bleeding disorders. This data is used to measure rates of complications of bleeding disorders and monitor trends over time (including inhibitors and other issues of blood and treatment product safety); identify high risk populations for prevention programs; and identify issues that require research. The purpose of this FOA is to continue the surveillance for these conditions through the HTCs. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Meredith Oakley
mco6@cdc.gov Email:mco6@cdc.gov |
DISPLAYING: Forecast 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD15-1507 |
| Funding Opportunity Title: | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.080 — Blood Disorder Program: Prevention, Surveillance, and Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Posted Date: | Jun 18, 2016 |
| Last Updated Date: | Jun 18, 2016 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | Jun 26, 2015 |
| Estimated Total Program Funding: | $21,500,000 |
| Award Ceiling: | $4,300,000 |
| Award Floor: | $100,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Applicants must demonstrate that they have access to a pool of at least 5000 (five thousand) patients with eligible bleeding disorder diagnoses. Eligible bleeding disorder diagnoses include hemophilia A or B, von Willebrand disease and rarer clotting factor deficiencies. This may be documented in the Target Population section of the Project Narrative. |
Additional Information
| Agency Name: | – |
| Description: | Since the 1990s the congressional budget has included funds for the the Centers for Disease Control and Prevention (CDC) to reduce or prevent the complications of hemophilia and other congenital bleeding disorders. Since 1996 the CDC has funded the federal network of hemophilia treatment centers (HTCs) for the collection of data for the monitoring of health indicators of importance to persons with bleeding disorders. This data is used to measure rates of complications of bleeding disorders and monitor trends over time (including inhibitors and other issues of blood and treatment product safety); identify high risk populations for prevention programs; and identify issues that require research. The purpose of this FOA is to continue the surveillance for these conditions through the HTCs. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:mco6@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD15-1507 |
| Funding Opportunity Title: | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.080 — Blood Disorder Program: Prevention, Surveillance, and Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | May 14, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Jun 19, 2015 |
| Estimated Total Program Funding: | $4,300,000 |
| Award Ceiling: | $4,300,000 |
| Award Floor: | $100,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Applicants must provide documentation that HTCs have agreed to collaborate with the awardee and CDC to carry out the strategies and activities relevant to the HTCs that are proposed for this project. This documentation may be in the form of letters of support, letters of agreement, memoranda of understanding, memoranda of agreement, or contracts from or with collaborating HTCs (hereafter referred to collectively as “letters of support”). Documentation from the regional core center on behalf of the participating HTCs within its region may be provided in place of individual documentation from each HTC. If letters of support are not provided, the applicant will be considered non-responsive. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | Since the 1990s the congressional budget has included funds for the the Centers for Disease Control and Prevention (CDC) to reduce or prevent the complications of hemophilia and other congenital bleeding disorders. Since 1996 the CDC has funded the federal network of hemophilia treatment centers (HTCs) for the collection of data for the monitoring of health indicators of importance to persons with bleeding disorders. This data is used to measure rates of complications of bleeding disorders and monitor trends over time (including inhibitors and other issues of blood and treatment product safety); identify high risk populations for prevention programs; and identify issues that require research. The purpose of this FOA is to continue the surveillance for these conditions through the HTCs. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Meredith Oakley
mco6@cdc.gov Email:mco6@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD15-1507 |
| Funding Opportunity Title: | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.080 — Blood Disorder Program: Prevention, Surveillance, and Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 13, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Jun 19, 2015 |
| Estimated Total Program Funding: | $4,300,000 |
| Award Ceiling: | $4,300,000 |
| Award Floor: | $100,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Applicants must provide documentation that HTCs have agreed to collaborate with the awardee and CDC to carry out the strategies and activities relevant to the HTCs that are proposed for this project. This documentation may be in the form of letters of support, letters of agreement, memoranda of understanding, memoranda of agreement, or contracts from or with collaborating HTCs (hereafter referred to collectively as “letters of support”). Documentation from the regional core center on behalf of the participating HTCs within its region may be provided in place of individual documentation from each HTC. If letters of support are not provided, the applicant will be considered non-responsive. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | Since the 1990s the congressional budget has included funds for the the Centers for Disease Control and Prevention (CDC) to reduce or prevent the complications of hemophilia and other congenital bleeding disorders. Since 1996 the CDC has funded the federal network of hemophilia treatment centers (HTCs) for the collection of data for the monitoring of health indicators of importance to persons with bleeding disorders. This data is used to measure rates of complications of bleeding disorders and monitor trends over time (including inhibitors and other issues of blood and treatment product safety); identify high risk populations for prevention programs; and identify issues that require research. The purpose of this FOA is to continue the surveillance for these conditions through the HTCs. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Meredith Oakley
mco6@cdc.gov Email:mco6@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD15-1507 |
| Funding Opportunity Title: | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.080 — Blood Disorder Program: Prevention, Surveillance, and Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 13, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 20, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Jun 19, 2015 |
| Estimated Total Program Funding: | $4,300,000 |
| Award Ceiling: | $4,300,000 |
| Award Floor: | $100,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Applicants must provide documentation that HTCs have agreed to collaborate with the awardee and CDC to carry out the strategies and activities relevant to the HTCs that are proposed for this project. This documentation may be in the form of letters of support, letters of agreement, memoranda of understanding, memoranda of agreement, or contracts from or with collaborating HTCs (hereafter referred to collectively as “letters of support”). Documentation from the regional core center on behalf of the participating HTCs within its region may be provided in place of individual documentation from each HTC. If letters of support are not provided, the applicant will be considered non-responsive. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | Since the 1990s the congressional budget has included funds for the the Centers for Disease Control and Prevention (CDC) to reduce or prevent the complications of hemophilia and other congenital bleeding disorders. Since 1996 the CDC has funded the federal network of hemophilia treatment centers (HTCs) for the collection of data for the monitoring of health indicators of importance to persons with bleeding disorders. This data is used to measure rates of complications of bleeding disorders and monitor trends over time (including inhibitors and other issues of blood and treatment product safety); identify high risk populations for prevention programs; and identify issues that require research. The purpose of this FOA is to continue the surveillance for these conditions through the HTCs. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Meredith Oakley
mco6@cdc.gov Email:mco6@cdc.gov |
Related Documents
Folder 275104 Full Announcement-2 -> dd15-1507 supporting documentation.pdf
Folder 275104 Full Announcement-3 -> dd15-1507 amendment 05.14.15.pdf
Packages
| Agency Contact Information: | Meredith Oakley mco6@cdc.gov Email: mco6@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.080 | CDC-RFA-DD15-1507 | Public Health Surveillance for the Prevention of Complications of Bleeding Disorders | PKG00215483 | Mar 13, 2015 | May 20, 2015 | View |
Package 1
Mandatory forms
275104 SF424_2_1-2.1.pdf
275104 SF424A-1.0.pdf
275104 HHS_CheckList_2_1-2.1.pdf
275104 Project-1.1.pdf
275104 Budget-1.1.pdf
Optional forms
275104 Other-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
